Valuation: OrganiGram Holdings Inc

Market Cap 184M 131M 115M 107M 98.38M 12.5B 188M 1.27B 497M 6.2B 491M 481M 21.42B P/E 2026 *
10.3x
P/E 2027 * 34.9x
Enterprise Value 184M 131M 115M 107M 98.38M 12.5B 188M 1.27B 497M 6.2B 491M 481M 21.42B EV / Sales 2026 *
0.55x
EV / Sales 2027 * 0.42x
Free-Float
69.74%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer - 15/01/2026
Director of Finance/CFO - 08/01/2024
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 65 29/03/2018
Director/Board Member 56 17/12/2018
Director/Board Member 70 17/12/2018
Change 5-day change 1-year change 3-year change Capi.($)
+4.72%+2.95% - - 131M
-4.15%-1.26%+42.39%+212.00% 234M
+2.12%+3.76%+2.12%+93.00% 133M
-3.75%-8.33%-10.47%-37.90% 81.19M
-0.21%-11.41%-29.34%-19.77% 77.04M
-2.81%-4.09%-45.37%-52.98% 51.04M
Average -0.68%-2.20%-8.13%+38.87% 115.21M
Weighted average by Cap. -0.76%-0.26%+8.31%+94.94%

Financials

2026 *2027 *
Net sales 336M 239M 209M 195M 179M 22.8B 342M 2.31B 905M 11.3B 896M 876M 39.06B 436M 310M 272M 253M 233M 29.59B 444M 3B 1.18B 14.68B 1.16B 1.14B 50.71B
Net income 18.08M 12.83M 11.26M 10.48M 9.64M 1.23B 18.38M 124M 48.68M 608M 48.16M 47.12M 2.1B 4M 2.84M 2.49M 2.32M 2.13M 271M 4.07M 27.52M 10.77M 135M 10.66M 10.43M 465M
Net Debt - -
Logo OrganiGram Holdings Inc
Organigram Global Inc. is focused on producing cannabis for adult recreational consumers, as well as developing international business partnerships. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. It operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. It operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-